Borea Therapeutics
Founded 2021 · 4 employees on LinkedIn · 1 known investors
Find your way into Borea Therapeutics
Borea Therapeutics develops gene therapy delivery technologies based on a proprietary AAV conjugation platform targeting neurological and genetic diseases. The company serves the therapeutic biotechnology market with precision neuronal targeting and advanced delivery strategies.
Founders & leadership
Borea Therapeutics was founded in 2021 by Paul Heppenstall.
PH
Paul HeppenstallScientific Co-Founder
NB
Niccolò BacchiinCEO
Investors · 1
In the news
Frequently asked questions
- What does Borea Therapeutics do?
- Borea Therapeutics develops gene therapy delivery technologies based on a proprietary AAV conjugation platform targeting neurological and genetic diseases. The company serves the therapeutic biotechnology market with precision neuronal targeting and advanced delivery strategies.
- Who founded Borea Therapeutics?
- Borea Therapeutics was founded by Paul Heppenstall in 2021.
- Who are Borea Therapeutics's investors?
- Borea Therapeutics's investors include Sofinnova Partners.